Pre-surgical predictive value of the EuroSCORE I, EuroSCORE II and STS score in patients undergoing cardiac surgery: preliminary report
Article Sidebar
Main Article Content
Abstract
Introduction: in cardiovascular surgery, the EuroSCORE I, EuroSCORE II and STS score are tools that provide prognosis and information for decision making. It is imperative to evaluate their real predictive value in our environment.
Objective: to evaluate the predictive value of the aforementioned scores in patients undergoing cardiac surgery in the Hospital Nacional cardiology area.
Methodology: retrospective cohort study, with non-probabilistic sampling of consecutive cases. The population consisted of patients undergoing cardiac surgery in the period from January 2020 to July 2021. 60 medical records were evaluated, 6 excluded, finally leaving 54 records.
Result: male sex predominated 57,14 %, the mean age was 60 ± 12 years (range 26 - 82 years old). The EuroSCORE II presented a relative risk of 10 (95 % CI 1.3 - 90), p = 0.004, sensitivity 80 %, specificity 78,43 %, PPV 26,67 % (95 % CI 0,95 to 52,38) and NPV 97,56 % (95 % CI 91,62 to 100 %). The EuroSCORE I presented a relative risk of 1.6 (95 % CI 0.2 - 10.9) p = 0.50, sensitivity 60 %, specificity 52,94 %, PPV 11,11 % (95 % CI 0.00 a 24,82) and NPV 93,10 % (95 % CI 82.16 to 100 %). The STS score yielded a relative risk of 3,5 (95 % CI 0.07 - 35), p = 0.10, sensitivity of 20 %, specificity 93,33 %, positive predictive value of 25 % (CI 95 % 0.00 to 79.93) and negative predictive value 91,30 % (95 % CI 82.07 to 100 %). Overall mortality was 8,93 % and morbidity 93 %.
Conclusion: a high negative predictive value was demonstrated in the scores, which determined that patients with low and intermediate risk had a low mortality.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Ruíz Estigarribia LM. Efectividad de los estudios preoperatorios en pacientes sanos sometidos a cirugías de bajo-moderado riesgo. Rev. virtual Soc. Parag. Med. Int. 2015;2(1)53-73. doi:10.18004/rvspmi/2312-3893/2015.02(01)53-073.
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9-13. doi: 10.1016/s1010-7940(99)00134-7.
Roques F, Michel P, Goldstone AR, Nashef SAM. The logistic EuroSCORE. European Heart Journal. 2003;24(9):882-2. doi: 10.1016/s0195-668x(02)00799-6.
Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734-44; discussion 744-745. doi: 10.1093/ejcts/ezs043.
O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23-42. doi: 10.1016/j.athoracsur.2009.05.056.
Shahian DM, O’Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2-22. doi:10.1016/j.athoracsur.2009.05.053
Shahian DM, O’Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S43-62. doi: 10.1016/j.athoracsur.2009.05.055.
Yap C-H, Reid C, Rowland MA, Mohajeri M, Skillington PD, Seevanayagam S, et al. Validation of the EuroSCORE model in Australia. European Journal of Cardio-thoracic Surgery. 2006;29(1):441-446. doi:10.1016/j.ejcts.2005.12.046.
Carosella VC, Mastantuono C, Golovonevsky V, Cohen V, Grancelli H, Rodriguez W, et al. Validación prospectiva y multicéntrica del ArgenSCORE en la cirugía de reemplazo valvular aórtico. Comparación con el EuroSCORE I y el EuroSCORE II. Rev Argent Cardiol. 2014;82(1): 6 -12.
Stavridis G, Panaretos D, Kadda O, Panagiotakos DB. Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: a prospective study. Open Cardiovasc Med J. 2017;11:94-101. doi: 10.2174/1874192401711010094.